MedTrace Logo

National Survey on Care Pathway and Quality of Life in Patients With Severe Asthma According to Their Phenotype.

NCT04438408 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2020-11-05

No results posted yet for this study

Summary

The SECOND SOUFFLE survey focuses on aspects of care and quality of life in a period when the landscape of severe asthma is changing in the context of biotherapies. Moreover survey on care pathway and quality of life of the asthmatic severe population according to their phenotype have never been done. It is likely to bring results in a relatively fast time, results that can lead to guide the criteria collected in RAMSES a national severe asthma cohort and future research tracks of this cohort.

Conditions

Interventions

OTHER

questionaires

patients will answer to questionnaires on the quality of life and the control of the asthmatic disease as well as the therapeutic observance.

Sponsors & Collaborators

  • AstraZeneca

    collaborator INDUSTRY

  • University Hospital, Toulouse

    lead OTHER

Principal Investigators

  • Didier Alain, Pr · University Hospital, Toulouse

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-01
Primary Completion
2021-09-01
Completion
2021-12-01

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04438408 on ClinicalTrials.gov